A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
Public ClinicalTrials.gov record NCT01143090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-Week, Flexible-Dose, Open-label Extension Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (Protocol No. D1050290)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone (lurasidone HCl) is a novel psychotropic agent that is being developed as a potential new antipsychotic treatment for patients with schizophrenia. Switching between antipsychotic medications is common in the treatment of schizophrenia. The purpose of this study is to characterize the long-term safety and tolerability of lurasidone in subjects with schizophrenia or schizoaffective disorder and to allow for continued treatment for subjects completing the core study (D1050289-NCT01143077).
Study identification
- NCT ID
- NCT01143090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2010 (Type not available)
- Primary completion
- Nov 2011 (Actual)
- Completion
- Not listed
- Last update posted
- Jun 12, 2015
Started 2010
United States locations
- U.S. sites
- 27
- U.S. states
- 12
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K and S Professional Research Services | Little Rock | Arkansas | 72201 | — |
| Synergy Clinical Research of Escondido | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove | California | 92845 | — |
| Pacific Research Partners, LLC | Oakland | California | 94612 | — |
| California Clinical Trials | Paramount | California | 90723 | — |
| Pasadena Research Institute | Pasadena | California | 91107 | — |
| California Neuropsychopharmacology Clinical Research Institute (CNRI), LLC | Pico Rivera | California | 90660 | — |
| California Neuropsychopharmacology Clinical Research Institute (CNRI) | San Diego | California | 92102 | — |
| University of California San Diego Medical Center | San Diego | California | 92103-8218 | — |
| Collaborative Neuroscience Network, South Bay | Torrance | California | 90502 | — |
| Western Affiliated Research Institute | Denver | Colorado | 80204 | — |
| Comprehensive NeuroScience, Inc. | Atlanta | Georgia | 30328 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70601 | — |
| St. Charles Psychiatric Associates - Midwest Research | Saint Charles | Missouri | 63301 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| The Zucker Hillside Hospital | Glen Oaks | New York | 11004 | — |
| Duke University Dept. of Psychiatry | Durham | North Carolina | 27710 | — |
| Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| CRI Worldwide - Kirkbride Center | Philadelphia | Pennsylvania | 19139 | — |
| FutureSearch Clinical Trials, LP | Austin | Texas | 78731 | — |
| FutureSearch Trials of Dallas | Dallas | Texas | 75231 | — |
| Pillar Clinical Research, LLC | Dallas | Texas | 75243 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Wharton Research Center | Wharton | Texas | 77488 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01143090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2015 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01143090 live on ClinicalTrials.gov.